A phase I pharmacokinetic study of NATESTO testosterone nasal gel in male patients with seasonal allergic rhinitis

Trial Profile

A phase I pharmacokinetic study of NATESTO testosterone nasal gel in male patients with seasonal allergic rhinitis

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Apr 2017 Results from this and NCT01446042 study investigating the impact of seasonal allergies on absorption of Natesto nasal gel in hypogonadal men, presented at The 99th Annual Meeting of the Endocrine Society.
    • 07 Jul 2016 New trial record
    • 17 Jun 2016 Results published in an Acerus Pharmaceuticals Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top